Clinical Trial Update: Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

This Phase 3 study compared duloxetine to placebo for relapse prevention in generalized anxiety disorder and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Anxiety Disorders | Phase 3 | Status: COMPLETED